表紙
市場調查報告書

全球分子診斷市場

Molecular Diagnostics

出版商 Global Industry Analysts, Inc. 商品編碼 138654
出版日期 內容資訊 英文 880 Pages
商品交期: 最快1-2個工作天內
價格
全球分子診斷市場 Molecular Diagnostics
出版日期: 2020年08月01日內容資訊: 英文 880 Pages
簡介

本報告提供全球分子診斷市場相關調查,彙整市場趨勢與各地區趨勢,2015∼2022年的預測,及加入此市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 預測
    • 全球體外診斷 (IVD) 市場踏實成長
    • 分子診斷:IVD市場中急速擴大的市場區隔
    • PCR技術領導分子診斷市場
    • 現在及未來分析
    • 美國及歐洲:市場領導
    • 發展中國家成長預測
    • 主要推動市場的要素
    • 市場趨勢
    • 技術趨勢
    • 分子診斷的進步
    • 主要的問題與課題
    • 市場預測
  • 促進成長要素與市場趨勢
    • 高齡化推動分子診斷市場
    • 全球的高齡人口統計:機會指標
    • 技術創新
    • 個人化醫療的分子診斷的作用
    • 搭配診斷趨勢 其他
  • 分子診斷的應用領域
    • 感染疾病
    • 子宮頸癌
    • HPV檢驗
    • 血液篩檢
    • 遺傳基因疾病檢驗
  • 分子診斷市場上競爭趨勢
    • 競爭環境概要
    • 關注企業
    • 主要企業的那個技術
  • 產品及技術概要
  • 產品認證/引進
  • 近幾年的產業活動
  • 主要企業
    • Abbott Laboratories
    • Abbott Molecular, Inc
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Cepheid
    • F. Hoffmann-La Roche Ltd.
    • GE Healthcare
    • Grifols International, S.A.
    • Hologic, Inc.
    • QIAGEN N.V.
    • Quest Diagnostics, Inc.
    • Siemens Healthcare GmBH
    • Tecan Group Ltd.
    • The ELITechGroup SAS
    • Thermo Fisher Scientific
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
  • 亞太地區
  • 南美

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1226

With PCR Tests Considered as the Gold Standard of Covid-19 Testing, Molecular Diagnostics Sees a 20.7% Spike in Revenues

The global market for Molecular Diagnostics is expected witness revenues spike by 20.7% in the year 2020 and thereafter continue to grow and reach US$19.9 billion by the year 2027, trailing a post COVID-19 CAGR of 9.8% over the analysisperiod2020 through 2027. Molecular diagnostic testing for COVID-19 is rapidly evolving each week as global infections continue to surge. Countries worldwide are stepping up testing rates significantly in a bid to control the spread of infections & mortality rates. India which is now in the eye of the pandemic storm is currently carrying out 1 million COVID-19 tests daily. The pressing requirement for massive and universal testing is leading to introduction of various technologies for COVID-19 diagnostics, providing access to new tests in response to the pandemic. These diagnostic techniques, along with approaches to develop new vaccines or therapies, rely heavily on molecules from the coronavirus, including nucleic acids such as DNA or RNA and proteins. COVID-19 diagnostics essentially screen samples for the viral RNA or the presence of antibodies for viral RNA. While viral RNA tests identify presence of SARS-CoV-2 infection from swab samples by reverse transcription of polymerase chain reaction (RT-PCR), immunoassay-based antibody tests delve deeper into the serum and diagnose presence of antibodies produced in the body and quantify the impact and resultant immunity attained. While RT-PCR tests are direct tests, antibody tests are to be paired with viral RNA tests and are not conclusive on their own and sometimes yield inconsistent results if the individual's immune system produces antibodies later than the time of the test.

As the gold standard in molecular diagnostics, PCR isa dominant way through which global healthcare systems are testing for Covid-19. These tests work by detecting the viral genomic material of the virus namely ribonucleic acid (RNA) which remains in the body while the virus replicates. Testing for COVID-19 detects genetic material of the virus from the lower and upper respiratory tract. Molecular tests use swab collection of the specimen from the mouth or nose of a person. The specimen is processed for the specific ribonucleic acid (RNA) or genetic signature of the SARS-CoV-2. Molecular tests are commonly used in acute respiratory infections for detecting the viral genetic material in specimens. The approach relies on reverse transcription polymerase chain reaction (RT-PCR) that involves copying and comparison of the genetic material from a specimen to the virus' genetic sequence. Molecular testing uses swab or saliva samples to detect the virus. The swab test involves insertion of a six inch swab into the back side of the nasal passage. The swab is rotated several times for collecting the sample from both nostrils, which is sent to a laboratory for testing. Abbott Laboratories has launched a point-of-care swab test intended to deliver test results in around five minutes. The availability of point-of-care or portable test kits allows sample collection in provider offices and even at a drive-thru site.

The FDA has recently authorized the foremost molecular test that considers saliva specimen. Offered by Rutgers' RUCDR Infinite Biologics, the test is accurate and addresses shortage of swabs. The FDA has allowed several companies to distribute molecular tests and notified various players to start testing people using internally-validated tests. Molecular diagnostics are gaining growing confidence in COVID 19 testing by virtue of their high specificity and accuracy RT-PCR tests in comparison with the cost efficient alternative - antibody tests that falter at authenticity of findings due to inconclusive early stage viral presence. The phenomenal rise in the COVID cases worldwide is poised to grow the market for molecular diagnostics multi-fold. With the recovery across the Asian, European and American markets falling into different stages, it is vital for the molecular diagnostics companies to be present in the right markets at the right time, vet their resources, scale up production, and optimize supply chains to overcome market specific hurdles, shortages, supply disruptions to pocket healthy volumes as long as the demand exists. Volumes may recede as the global infections go down gradually, or are contingent upon the development of the vaccine by 2021. In the post COVID-19 period, demand for molecular diagnostics will grow stronger with pent-up demand for infectious disease testing such as tuberculosis, hepatitis C, hepatitis B, HPV, and also STDs.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Cepheid
  • F. Hoffmann-La Roche Ltd.
  • Grifols International S.A.
  • Hologic Inc.
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Siemens Healthineers
  • Tecan Group Ltd.
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • Molecular Diagnostics Receive Healthy Booster from CoVid-19 Tests
    • EXHIBIT 1: Total Number of COVID-19 Tests Conducted in the Most Impacted Countries
    • Molecular Diagnostics Receive Healthy Booster from CoVid-19 Tests
    • RT-PCR Emerges as the Frontline Technology for Testing COVID-19
    • Performance Analysis of COVID-19 Tests
    • Need of the Hour: RT-PCR Shortages to be Tackled Effectively by Molecular Diagnostics Companies
    • Molecular Diagnostic Companies Re-strategize Logistics to Stay at the Top End of the Game
    • Select Tests Introduced for COVID-19
    • COVID-19 Plunges Fortunes of Non- COVID Diagnostics
    • Cancer Testing Dives During First Half of 2020
    • Myeloproliferative Neoplasm Tests Suffer the Brunt of CoVID-19 Curbs
    • Labs Embark New Journeys to Retain Overall Volumes
    • Molecular Diagnostics: An Introduction
    • Types of Molecular Diagnostics Tests
    • Market Outlook
    • Major Growth Drivers
    • Developing Countries Offer Strong Growth Prospects
    • PCR Technology Leads the MDx Market
    • Infectious Diseases: The Largest Application Market
    • Reagents and Kits Dominate the Molecular Diagnostics Market
    • Competition
    • EXHIBIT 2: Global Molecular Diagnostics Market by Leading Player (2019)
    • EXHIBIT 3: Global Molecular Diagnostics Market for Clostridium difficile by Leading Player: 2019
    • Pharmaceutical Firms Carve their Niche in Molecular Diagnostic Market
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Faster Screening Necessitates Point-of-Care Diagnostics for COVID-19
    • Molecular Diagnostics Market Eyes Transformational Impact of Proactive Diagnostics
    • Next-Generation Sequencing to Emerge as Novel Technique in Fight with COVID-19
    • Isothermal Amplification: An Alternative to RT-PCR for COVID-19 Testing
    • Technological Innovations Set to Drive Market Growth
    • New Product Developments
    • Digitalization, Automation and AI Trends Reshape Growth
    • Growing Role of Molecular Diagnostics in Personalized Medicine
    • EXHIBIT 4: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Companion Diagnostics Drive Personalized Medicine
    • Biomarkers as Companion Diagnostics
    • Oncology-Based Molecular Diagnostics Lead Growth
    • EXHIBIT 5: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • EXHIBIT 6: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
    • EXHIBIT 7: Number of New Cancer Cases and Deaths (in Million) by Region for 2018
    • New Applications Hold Promising Potential
    • Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum
    • Rising Emphasis on Lab Automation to Augur Well for Market Growth
    • EXHIBIT 8: World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
    • Nanotechnology for Molecular Diagnostics
    • Growing Popularity of Chemo-Sensitivity Testing of CTCs
    • Genetic Disease Testing Offers Bright Prospects
    • Genetic Testing to Aid in Personalized Medicine
    • Pharmacogenomics Development Augurs Growth of Genetic Testing Market
    • Non-Invasive Prenatal Diagnostics - The Way Ahead
    • Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
    • Growing Incidence of Infectious Diseases Spurs Opportunities
    • EXHIBIT 9: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
    • PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
    • Rising Incidence of Hospital Acquired Infections Propels Market Growth
    • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
    • EXHIBIT 10: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
    • EXHIBIT 11: Number of AIDS-Related Deaths (in Thousands) by Region for 2018
    • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
    • Home HIV Testing Emerges as a Lucrative Option
    • Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market
    • Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing
    • EXHIBIT 12: Hepatitis B prevalence Worldwide by Region
    • HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market
    • EXHIBIT 13: HPV Associated Disorders Market by Indication: 2019
    • Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing
    • EXHIBIT 14: Number of New Cervix Uteri Cases in the World by Region (2018)
    • Molecular based Tests Ingrain Roots in Blood Donor Screening Segment
    • Rise in Healthcare Expenditure to Drive Growth
    • EXHIBIT 15: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Aging Population Drives Molecular Diagnostics Market
    • EXHIBIT 16: Elderly Healthcare Expenditure as a % of GDP
    • EXHIBIT 17: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 2: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 11: World Historic Review for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Software & Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 14: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 17: World Historic Review for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for In-Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 20: World Historic Review for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Isothermal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 23: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 26: World Historic Review for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 27: World 15-Year Perspective for Chips & Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 29: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 30: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 32: World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 33: World 15-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 35: World Historic Review for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 36: World 15-Year Perspective for Oncology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 37: World Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 38: World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 39: World 15-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 40: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 41: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 42: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Overview
    • EXHIBIT 18: Healthcare Spending as a % of GDP in the US: 2010-2020
    • US Emerges as a Major Market for COVID-19 Tests
    • FDA Plays Instrumental Role in Influx of New Tests
    • Select COVID-19 Test Kits with FDA Authorization
    • EXHIBIT 19: Cumulative Number of COVI-19 Tests Performed in the US (In '000): 31-Mar-30 July 2020
    • NIH Launches Initiative to Encourage Innovation
    • Infectious Disease Testing Contributes to High Growth
    • Ageing Demographics: Major Driving Factor
    • EXHIBIT 20: US Elderly Population: Expected Growth Rates Over the Years 2005-2025
    • Increasing Incidence of Chronic Diseases Drives Focus onto Molecular Diagnostics
    • Rising Incidence of Cancer: A Major Growth Driver
    • EXHIBIT 21: Leading Sites of New Cancer Cases in Males: 2020
    • EXHIBIT 22: Leading Sites of New Cancer Cases in Females: 2020
    • Molecular Diagnostics Tests Gain Share in STD Testing Domain
    • HPV Testing Market: A Review
    • EXHIBIT 23: Prevalence of HPV in the US by Age
    • US Personalized Medicine Market to Offer Significant Opportunities
    • Companion Diagnostics Market in the US
    • Burgeoning Potential for Genetic Testing
    • Paradigm Shift amongst Consumers Spurs DTC Genetic Testing Market
    • Market Analytics
    • TABLE 43: USA Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 44: USA Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 45: USA 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 46: USA Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 47: USA Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 48: USA 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 49: USA Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 50: USA Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 51: USA 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 52: Canada Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 53: Canada Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 54: Canada 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 55: Canada Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 56: Canada Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 57: Canada 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 58: Canada Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 59: Canada Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 60: Canada 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • JAPAN
    • Market Overview
    • Brief Note on COVID-19 Testing in Japan
    • Demographics Drive Market Growth
    • EXHIBIT 24: Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
    • Market Analytics
    • TABLE 61: Japan Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 62: Japan Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 63: Japan 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 64: Japan Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 65: Japan Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 66: Japan 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 67: Japan Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 68: Japan Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 69: Japan 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • CHINA
    • Market Overview
    • COVID-19 Testing: An Overview
    • HPV Testing in China
    • Market Analytics
    • TABLE 70: China Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 71: China Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 72: China 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 73: China Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 74: China Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 75: China 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 76: China Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 77: China Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 78: China 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Overview
    • COVID-19 Testing Drives Revenue Growth
    • Covid-19 Testing in the UK
    • Aging Population: A Prime Growth Driver
    • Automated Systems Gain Preeminence
    • Oncology-based Molecular Diagnostics Holds Immense Potential
    • EXHIBIT 25: Number of New Cancer Cases in Europe: 2012, 2018, and 2025
    • EXHIBIT 26: Distribution of New Cancer Cases by Type in Europe: 2018
    • HPV Testing in Europe: An Overview
    • Market Analytics
    • TABLE 79: Europe Current & Future Analysis for Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 80: Europe Historic Review for Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 81: Europe 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 82: Europe Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 83: Europe Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 84: Europe 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 85: Europe Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 86: Europe Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 87: Europe 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 88: Europe Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 89: Europe Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 90: Europe 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 91: France Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 92: France Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 93: France 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 94: France Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 95: France Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 96: France 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 97: France Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 98: France Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 99: France 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 100: Germany Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 101: Germany Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 102: Germany 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 103: Germany Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 104: Germany Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 105: Germany 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 106: Germany Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 107: Germany Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 108: Germany 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 109: Italy Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 110: Italy Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 111: Italy 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 112: Italy Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 113: Italy Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 114: Italy 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 115: Italy Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 116: Italy Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 117: Italy 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 118: UK Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 119: UK Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 120: UK 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 121: UK Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 122: UK Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 123: UK 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 124: UK Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 125: UK Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 126: UK 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 127: Spain Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 128: Spain Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 129: Spain 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 130: Spain Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 131: Spain Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 132: Spain 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 133: Spain Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 134: Spain Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 135: Spain 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 136: Russia Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 137: Russia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 138: Russia 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 139: Russia Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 140: Russia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 141: Russia 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 142: Russia Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 143: Russia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 144: Russia 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 145: Rest of Europe Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 146: Rest of Europe Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 147: Rest of Europe 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 148: Rest of Europe Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 149: Rest of Europe Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 150: Rest of Europe 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 151: Rest of Europe Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 152: Rest of Europe Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 153: Rest of Europe 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • Market Overview
    • Healthcare Spending in Asia-Pacific: On the Rise
    • Market Analytics
    • TABLE 154: Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 155: Asia-Pacific Historic Review for Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 156: Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 157: Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 158: Asia-Pacific Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 159: Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 160: Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 161: Asia-Pacific Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 162: Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 163: Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 164: Asia-Pacific Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 165: Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 166: Australia Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 167: Australia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 168: Australia 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 169: Australia Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 170: Australia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 171: Australia 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 172: Australia Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 173: Australia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 174: Australia 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • INDIA
    • Market Overview
    • Laboratories Pick up on Automation
    • HPV Testing Market: An Overview
    • EXHIBIT 27: HPV in India: Breakdown of Type-Distribution and HPV Prevalence
    • Market Analytics
    • TABLE 175: India Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 176: India Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 177: India 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 178: India Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 179: India Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 180: India 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 181: India Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 182: India Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 183: India 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 184: South Korea Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 185: South Korea Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 186: South Korea 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 187: South Korea Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 188: South Korea Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 189: South Korea 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 190: South Korea Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 191: South Korea Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 192: South Korea 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 193: Rest of Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 194: Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 195: Rest of Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 196: Rest of Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 197: Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 198: Rest of Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 199: Rest of Asia-Pacific Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 200: Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 201: Rest of Asia-Pacific 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 202: Latin America Current & Future Analysis for Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 203: Latin America Historic Review for Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 204: Latin America 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 205: Latin America Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 206: Latin America Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 207: Latin America 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 208: Latin America Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 209: Latin America Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 210: Latin America 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 211: Latin America Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 212: Latin America Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 213: Latin America 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 214: Argentina Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 215: Argentina Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 216: Argentina 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 217: Argentina Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 218: Argentina Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 219: Argentina 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 220: Argentina Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 221: Argentina Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 222: Argentina 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 223: Brazil Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 224: Brazil Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 225: Brazil 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 226: Brazil Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 227: Brazil Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 228: Brazil 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 229: Brazil Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 230: Brazil Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 231: Brazil 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 232: Mexico Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 233: Mexico Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 234: Mexico 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 235: Mexico Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 236: Mexico Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 237: Mexico 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 238: Mexico Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 239: Mexico Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 240: Mexico 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 241: Rest of Latin America Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 242: Rest of Latin America Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 243: Rest of Latin America 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 244: Rest of Latin America Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 245: Rest of Latin America Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 246: Rest of Latin America 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 247: Rest of Latin America Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 248: Rest of Latin America Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 249: Rest of Latin America 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 250: Middle East Current & Future Analysis for Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 251: Middle East Historic Review for Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 252: Middle East 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 253: Middle East Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 254: Middle East Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 255: Middle East 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 256: Middle East Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 257: Middle East Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 258: Middle East 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 259: Middle East Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 260: Middle East Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 261: Middle East 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 262: Iran Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 263: Iran Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 264: Iran 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 265: Iran Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 266: Iran Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 267: Iran 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 268: Iran Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 269: Iran Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 270: Iran 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 271: Israel Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 272: Israel Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 273: Israel 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 274: Israel Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 275: Israel Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 276: Israel 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 277: Israel Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 278: Israel Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 279: Israel 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 280: Saudi Arabia Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 281: Saudi Arabia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 282: Saudi Arabia 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 283: Saudi Arabia Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 284: Saudi Arabia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 285: Saudi Arabia 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 286: Saudi Arabia Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 287: Saudi Arabia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 288: Saudi Arabia 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 289: UAE Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 290: UAE Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 291: UAE 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 292: UAE Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 293: UAE Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 294: UAE 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 295: UAE Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 296: UAE Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 297: UAE 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 298: Rest of Middle East Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 299: Rest of Middle East Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 300: Rest of Middle East 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 301: Rest of Middle East Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 302: Rest of Middle East Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 303: Rest of Middle East 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 304: Rest of Middle East Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 305: Rest of Middle East Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 306: Rest of Middle East 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 307: Africa Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 308: Africa Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 309: Africa 15-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2012, 2020 & 2027
    • TABLE 310: Africa Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 311: Africa Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 312: Africa 15-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 313: Africa Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 314: Africa Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 315: Africa 15-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 84